Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Triple Therapy with Levofloxacin for H. pylori
NCT02596620Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of metronidazole in Helicobacter pylori infection, sponsored by Chang Gung Memorial Hospital. Primary endpoint: Percentage of Participants With Successful Eradication of H. Pylori at 4 weeks. Started Oct 2013; status: completed.
02
Drugs
metronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02596620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596620.